Made Scientific, a leading clinical- and commercial-enabling cell therapy contract development and manufacturing organization ...
GeminiBio announces aiMOS™, an AI-enabled media optimization service designed to enhance cell therapy performance and manufacturing outcomes.
Interesting Engineering on MSN
First-ever experimental gene therapy seeks to restore vision by rejuvenating eye neurons
Life Biosciences is pushing cellular rejuvenation into the clinic with ER-100, an experimental gene ...
Kincell Bio, a leading U.S. cell therapy contract development and manufacturing organization (CDMO), today announced a new collaboration with RegCell, a biotechnology company developing first‑in‑class ...
Aviva Bio is advancing AVA-291 (d3-T) as a differentiated testosterone in a broad development program addressing multiple ...
Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced new clinical data presented at the 2026 Tandem ...
The last time I spoke about INmune Bio (INMB) it was with a Seeking Alpha article entitled "INmune Bio: Alzheimer's Disease Treatment Lottery Ticket". With this article, I noted its prospects about ...
2seventy bio (NASDAQ:TSVT) shares popped nearly 4% premarket on Tuesday after it entered a deal to be acquired by Bristol Myers Squibb (NYSE:BMY) in an ~$286M all-cash transaction (or $102M net of ...
Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...
Bluebird Bio, Inc. (NASDAQ:BLUE) received an unsolicited, non-binding written proposal from Ayrmid Ltd. on Friday. Ayrmid has proposed to acquire Bluebird for an upfront cash payment of $4.50 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results